Netherlands Wound Care Management Investment Opportunities

Analysis and Forecasts to 2012

Product Code GMD07503
Publication Date September 2008
Publisher Global Markets Direct
Product Type Report
Pages 172
ISBN Number not applicable
Change currency
PDF £1,895.00 €2,282 $2,996 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Netherlands Wound Care Management Investment Opportunities

Analysis and Forecasts to 2012

This report is an essential source for in-depth information and data relating to Netherlands wound care management market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Netherlands

Scope

  • The report provides wound care management information broken down into detailed categories and segments in Netherlands.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the wound care management market in Netherlands.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Contents

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
    • 2.2 Definitions
      • 2.2.1 Wound Care Management
  • 3 Healthcare Sector Review
    • 3.1 Healthcare Expenditure
    • 3.2 Healthcare Infrastructure
    • 3.3 Healthcare Policy
      • 3.3.1 Health Insurance Act
      • 3.3.2 Healthcare Allowance Act
      • 3.3.3 The Exceptional Medical Expenses Act
  • 4 Wound Care Management in Netherlands
    • 4.1 Wound Care Management Overall Revenues (2000-2012)
    • 4.2 Wound Care Management Overall Volume (2000-2012)
    • 4.3 Wound Care Management Overall Company Shares (2005-2006)
  • 5 Wound Closure Devices in Netherlands
    • 5.1 Wound Closure Devices Overall Revenues (2000-2012)
      • 5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
      • 5.1.2 Hemostats Overall Revenues (2000-2012)
      • 5.1.3 Tissue Sealants Overall Revenues (2000-2012)
    • 5.2 Wound Closure Devices Overall Volume (2000-2012)
      • 5.2.1 Skin Closure Devices Overall Volume (2000-2012)
      • 5.2.2 Tissue Sealants Overall Volume (2000-2012)
      • 5.2.3 Hemostats Overall Volume (2000-2012)
    • 5.3 Wound Closure Devices Average Price (2000-2012)
      • 5.3.1 Hemostats Average Price (2000-2012)
      • 5.3.2 Tissue Sealants Average Price (2000-2012)
      • 5.3.3 Skin Closure Devices Average Price (2000-2012)
    • 5.4 Wound Closure Devices Distribution Share (2000-2012)
    • 5.5 Wound Closure Devices Company Share (2000-2012)
  • 6 Ostomy in Netherlands
    • 6.1 Ostomy Overall Revenue (2000-2012)
    • 6.2 Ostomy Overall Volume (2000-2012)
    • 6.3 Ostomy Average Price (2000-2012)
    • 6.4 Ostomy Distribution Share (2005-2006)
    • 6.5 Ostomy Company Share (2005-2006)
  • 7 Advanced Wound Management in Netherlands
    • 7.1 Advanced Wound Management Overall Revenue (2000-2012)
    • 7.2 Advanced Wound Management Overall Volume (2000-2012)
    • 7.3 Advanced Wound Management Average Price (2000-2012)
    • 7.4 Advanced Wound Management Distribution Share (2005-2006)
    • 7.5 Advanced Wound Management Company Share (2005-2006)
  • 8 Traditional Wound Management in Netherlands
    • 8.1 Traditional Wound Management Overall Revenue (2000-2012)
    • 8.2 Traditional Wound Management Overall Volume (2000-2012)
    • 8.3 Traditional Wound Management Average Price (2000-2012)
    • 8.4 Traditional Wound Management Distribution Share (2000-2012)
    • 8.5 Traditional Wound Management Company Share (2000-2012)
  • 9 Compression Therapy in Netherlands
    • 9.1 Compression Therapy Overall Revenue (2000-2012)
    • 9.2 Compression Therapy Category Volume (2000-2012)
    • 9.3 Compression Therapy Average Price (2000-2012)
    • 9.4 Compression Therapy Distribution Share (2000-2012)
    • 9.5 Compression Therapy Company Share (2000-2012)
  • 10 Baxter International Company Profile
    • 10.1 Company Overview
    • 10.2 Business Overview
      • 10.2.1 BioScience
      • 10.2.2 Medication Delivery
      • 10.2.3 Renal
      • 10.2.4 Products
      • 10.2.5 History
    • 10.3 Value Chain Analysis
      • 10.3.1 Manufacturing
      • 10.3.2 Product Development
      • 10.3.3 Sales and Marketing
    • 10.4 SWOT Analysis
      • 10.4.1 Baxter International Inc. Strengths
      • 10.4.2 Baxter International Inc. Weaknesses
      • 10.4.3 Baxter International Inc. Opportunities
      • 10.4.4 Baxter International Inc. Threats
    • 10.5 Financial and Operational Review
    • 10.6 Locations And Subsidiaries
    • 10.7 Baxter International Inc. Pipeline Products
      • 10.7.1 Next-Generation Home Hemodialysis Machine
  • 11 Smith & Nephew Plc Company Profile
    • 11.1 Company Overview
    • 11.2 Business Overview
      • 11.2.1 Advanced Wound Management
      • 11.2.2 Endoscopy
      • 11.2.3 Reconstruction
      • 11.2.4 Trauma and Clinical Therapies
      • 11.2.5 Products
      • 11.2.6 History
    • 11.3 Value Chain Analysis
      • 11.3.1 Manufacturing
      • 11.3.2 Product Development
      • 11.3.3 Sales and Marketing
    • 11.4 SWOT Analysis
      • 11.4.1 Smith & Nephew Plc Strengths
      • 11.4.2 Smith & Nephew Plc Weaknesses
      • 11.4.3 Smith & Nephew Plc Opportunities
      • 11.4.4 Smith & Nephew Plc Threats
    • 11.5 Financial and Operational Review
    • 11.6 Locations And Subsidiaries
    • 11.7 Smith & Nephew Plc Pipeline Products
      • 11.7.1 R3 Modular resurfacing Acetabular system
      • 11.7.2 R3 Ceramic-on-ceramic Acetabular System
  • 12 The HARTMANN GROUP Company Profile
    • 12.1 Company Overview
    • 12.2 Business Overview
      • 12.2.1 Incontinence Management
      • 12.2.2 Operating Theater Management
      • 12.2.3 Other GROUP Activities
      • 12.2.4 Wound Management
      • 12.2.5 Products
      • 12.2.6 History
    • 12.3 Value Chain Analysis
      • 12.3.1 Manufacturing
      • 12.3.2 Product Development
      • 12.3.3 Sales and Marketing
    • 12.4 SWOT Analysis
      • 12.4.1 HARTMANN GROUP Strengths
      • 12.4.2 HARTMANN GROUP Weaknesses
      • 12.4.3 HARTMANN GROUP Opportunities
      • 12.4.4 HARTMANN GROUP Threats
    • 12.5 Financial and Operational Review
    • 12.6 Locations And Subsidiaries
  • 13 Coloplast A/S Company Profile
    • 13.1 Company Overview
    • 13.2 Business Overview
      • 13.2.1 Medical Care
      • 13.2.2 Major Products and Services
      • 13.2.3 History
    • 13.3 Value Chain Analysis
      • 13.3.1 Manufacturing
      • 13.3.2 Product Development
      • 13.3.3 Sales and Marketing
    • 13.4 SWOT Analysis
      • 13.4.1 Coloplast A/S Strengths
      • 13.4.2 Coloplast A/S Weaknesses
      • 13.4.3 Coloplast A/S Opportunities
      • 13.4.4 Coloplast A/S Threats
    • 13.5 Financial and Operational Review
      • 13.5.1 Financial Statements
      • 13.5.2 Financial Ratios
      • 13.5.3 Share Holding Structure
    • 13.6 Locations And Subsidiaries
  • 14 ConvaTec Company Profile
    • 14.1 Company Overview
    • 14.2 Business Overview
      • 14.2.1 Major Products and Services
      • 14.2.2 History
    • 14.3 Locations And Subsidiaries
  • 15 Regulation System
    • 15.1 Medical Equipment Approval Process
      • 15.1.1 Classification of Medical Devices
      • 15.1.2 Conformity Assessment Process
    • 15.2 Post Market Surveillance (PMS)
  • 16 Pricing and Reimbursement
    • 16.1 Pricing and Reimbursement in Netherlands
  • 17 Distribution Structure
    • 17.1 Distribution Structure in Netherlands
  • 18 Financial Deals Landscape
    • 18.1 Acquisition
      • 18.1.1 aap Implantate Acquires Fame Holding
  • 19 Appendix
    • 19.1 Global Markets Direct Research Methodology
    • 19.2 Coverage
    • 19.3 Secondary Research
    • 19.4 Primary Research
    • 19.5 Models
    • 19.6 Forecasts
    • 19.7 Expert Panels
    • 19.8 Currency Conversion
    • 19.9 Contact Us
    • 19.10 Disclaimer
  • 1 List of Tables
    • Table 1: Doctors by Specialty in Netherlands, 2000-2006
    • Table 2: Hospital Wards by Type in Netherlands, 2000-2006
    • Table 3: Wound Care Management, Netherlands, Overall Revenues ($ mn), 2000-2012
    • Table 4: Wound Care Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 5: Wound Care Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 6: Wound Care Management, Netherlands, Category Revenues ($ mn), 2000-2012
    • Table 7: Wound Care Management, Netherlands, Category Revenues ($ mn), Historic, 2000-2007
    • Table 8: Wound Care Management, Netherlands, Category Revenues ($ mn), Forecast, 2007-2012
    • Table 9: Wound Care Management, Netherlands, Category Volume (Units), 2000-2012
    • Table 10: Wound Care Management, Netherlands, Category Volume (Units), Historic, 2000-2007
    • Table 11: Wound Care Management, Netherlands, Category Volume (Units), Forecast, 2007-2012
    • Table 12: Wound Care Management, Netherlands, Overall Company Share by Revenue ($ mn), 2005-2006
    • Table 13: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 14: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 15: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Historic, 2000-2007
    • Table 16: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Table 17: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 18: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 19: Hemostats, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 20: Hemostats, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 21: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 22: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 23: Wound Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 24: Wound Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 25: Skin Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 26: Skin Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 27: Tissue Sealants, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 28: Tissue Sealants, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 29: Hemostats, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 30: Hemostats, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 31: Hemostats, Netherlands, Average Price ($), Historic, 2000-2007
    • Table 32: Hemostats, Netherlands, Average Price ($), Forecast, 2007-2012
    • Table 33: Tissue Sealants, Netherlands, Average Price ($), Historic, 2000-2007
    • Table 34: Tissue Sealants, Netherlands, Average Price ($), Forecast, 2007-2012
    • Table 35: Skin Closure Devices, Netherlands, Average Price ($), Historic, 2000-2007
    • Table 36: Skin Closure Devices, Netherlands, Average Price ($), Forecast, 2007-2012
    • Table 37: Wound Closure Devices, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 38: Wound Closure Devices, Netherlands, Company Share by Revenue ($ mn), 2005-2006
    • Table 39: Ostomy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 40: Ostomy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 41: Ostomy, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 42: Ostomy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 43: Ostomy, Netherlands, Average Price ($), Historic, 2000-2007
    • Table 44: Ostomy, Netherlands, Average Price ($), Forecast, 2007-2012
    • Table 45: Ostomy, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 46: Ostomy, Netherlands, Company Share by Revenue ($ mn), 2005-2006
    • Table 47: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 48: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 49: Advanced Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 50: Advanced Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 51: Advanced Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
    • Table 52: Advanced Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
    • Table 53: Advanced Wound Management, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 54: Advanced Wound Management, Netherlands, Company Share by Revenue ($ mn), 2005-2006
    • Table 55: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 56: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 57: Traditional Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 58: Traditional Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 59: Traditional Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
    • Table 60: Traditional Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
    • Table 61: Traditional Wound Management, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 62: Traditional Wound Management, Netherlands, Company Share by Revenue ($ mn), 2005-2006
    • Table 63: Compression Therapy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Table 64: Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Table 65: Compression Therapy, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Table 66: Compression Therapy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Table 67: Compression Therapy, Netherlands, Average Price ($), Historic, 2000-2007
    • Table 68: Compression Therapy, Netherlands, Average Price ($), Forecast, 2007-2012
    • Table 69: Compression Therapy, Netherlands, Distribution Share by Revenue ($ mn), 2005-2006
    • Table 70: Compression Therapy, Netherlands, Company Share by Revenue ($ mn), 2005-2006
    • Table 71: Baxter International Inc., SWOT Analysis, 2006
    • Table 72: Baxter International Inc., Financial Statements, USD Million, 2002-2006
    • Table 73: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
    • Table 74: Baxter International Inc., Other Locations
    • Table 75: Baxter International Inc., Subsidiaries
    • Table 76: Smith & Nephew Plc, SWOT Analysis, 2006
    • Table 77: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
    • Table 78: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006
    • Table 79: Smith & Nephew Plc, Other Locations
    • Table 80: HARTMANN GROUP, SWOT Analysis, 2006
    • Table 81: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006
    • Table 82: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006
    • Table 83: HARTMANN GROUP, Subsidiaries
    • Table 84: Coloplast A/S, SWOT Analysis, 2007
    • Table 85: Coloplast A/S, Financial Statements, DKK Million, 2003-2007
    • Table 86: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007
    • Table 87: Coloplast A/S, Share Holding Structure
    • Table 88: Coloplast A/S, Other Locations
    • Table 89: Coloplast A/S, Subsidiaries
    • Table 90: ConvaTec, Other Locations
    • Table 91: Currency Conversion from USD to Local Currency at 2007 Constant Rate
    • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2006
    • Figure 2: Healthcare Financing Framework in Netherlands, 2005
    • Figure 3: Wound Care Management, Netherlands, Overall Revenues ($ mn), 2000-2012
    • Figure 4: Wound Care Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 5: Wound Care Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 6: Wound Care Management, Netherlands, Category Revenues ($ mn), 2000-2012
    • Figure 7: Wound Care Management, Netherlands, Category Revenues ($ mn), Historic, 2000-2007
    • Figure 8: Wound Care Management, Netherlands, Category Revenues ($ mn), Forecast, 2007-2012
    • Figure 9: Wound Care Management, Netherlands, Category Volume (Units), 2000-2012
    • Figure 10: Wound Care Management, Netherlands, Category Volume (Units), Historic, 2000-2007
    • Figure 11: Wound Care Management, Netherlands, Category Volume (Units), Forecast, 2007-2012
    • Figure 12: Wound Care Management, Netherlands, Overall Company Share (%), 2006
    • Figure 13: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 14: Wound Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 15: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Historic, 2000-2007
    • Figure 16: Wound Closure Devices, Netherlands, Revenue by Segment ($ mn), Forecast, 2007-2012
    • Figure 17: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 18: Skin Closure Devices, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 19: Hemostats, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 20: Hemostats, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 21: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 22: Tissue Sealants, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 23: Wound Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 24: Wound Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 25: Skin Closure Devices, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 26: Skin Closure Devices, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 27: Tissue Sealants, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 28: Tissue Sealants, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 29: Hemostats, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 30: Hemostats, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 31: Hemostats, Netherlands, Average Price ($), Historic, 2000-2007
    • Figure 32: Hemostats, Netherlands, Average Price ($), Forecast, 2007-2012
    • Figure 33: Tissue Sealants, Netherlands, Average Price ($), Historic, 2000-2007
    • Figure 34: Tissue Sealants, Netherlands, Average Price ($), Forecast, 2007-2012
    • Figure 35: Skin Closure Devices, Netherlands, Average Price ($), Historic, 2000-2007
    • Figure 36: Skin Closure Devices, Netherlands, Average Price ($), Forecast, 2007-2012
    • Figure 37: Wound Closure Devices, Netherlands, Distribution Share (%), 2006
    • Figure 38: Wound Closure Devices, Netherlands, Company Share (%), 2006
    • Figure 39: Ostomy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 40: Ostomy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 41: Ostomy, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 42: Ostomy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 43: Ostomy, Netherlands, Average Price ($), Historic, 2000-2007
    • Figure 44: Ostomy, Netherlands, Average Price ($), Forecast, 2007-2012
    • Figure 45: Ostomy, Netherlands, Company Share (%), 2006
    • Figure 46: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 47: Advanced Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 48: Advanced Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 49: Advanced Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 50: Advanced Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
    • Figure 51: Advanced Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
    • Figure 52: Advanced Wound Management, Netherlands, Distribution Share (%), 2006
    • Figure 53: Advanced Wound Management, Netherlands, Company Share (%), 2006
    • Figure 54: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 55: Traditional Wound Management, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 56: Traditional Wound Management, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 57: Traditional Wound Management, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 58: Traditional Wound Management, Netherlands, Average Price ($), Historic, 2000-2007
    • Figure 59: Traditional Wound Management, Netherlands, Average Price ($), Forecast, 2007-2012
    • Figure 60: Traditional Wound Management, Netherlands, Distribution Share (%), 2006
    • Figure 61: Traditional Wound Management, Netherlands, Company Share (%), 2006
    • Figure 62: Compression Therapy, Netherlands, Overall Revenues ($ mn), Historic, 2000-2007
    • Figure 63: Compression Therapy, Netherlands, Overall Revenues ($ mn), Forecast, 2007-2012
    • Figure 64: Compression Therapy, Netherlands, Overall Volume (Units), Historic, 2000-2007
    • Figure 65: Compression Therapy, Netherlands, Overall Volume (Units), Forecast, 2007-2012
    • Figure 66: Compression Therapy, Netherlands, Average Price ($), Historic, 2000-2007
    • Figure 67: Compression Therapy, Netherlands, Average Price ($), Forecast, 2007-2012
    • Figure 68: Compression Therapy, Netherlands, Distribution Share (%), 2006
    • Figure 69: Compression Therapy, Netherlands, Company Share (%), 2006
    • Figure 70: Baxter International Inc., Value Chain Analysis
    • Figure 71: Smith & Nephew Plc, Value Chain Analysis
    • Figure 72: HARTMANN GROUP, Value Chain Analysis
    • Figure 73: Coloplast A/S, Value Chain Analysis
    • Figure 74: Flowchart for Classification of Non-invasive Devices in Netherlands, 2007
    • Figure 75: Flowchart for Classification of Invasive Devices in Netherlands, 2007
    • Figure 76: Flowchart for Classification of Invasive Devices in Netherlands, 2007
    • Figure 77: Flowchart for Classification of Invasive Devices in Netherlands, 2007
    • Figure 78: Flowchart for Classification of Invasive Devices in Netherlands, 2007
    • Figure 79: Flowchart for Classification of Active Devices in Netherlands, 2007
    • Figure 80: Flowchart for Classification of Active Devices in Netherlands, 2007
    • Figure 81: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Netherlands, 2007
    • Figure 82: Conformity Assessment of Class-I Medical Devices in Netherlands, 2007
    • Figure 83: Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007
    • Figure 84: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007
    • Figure 85: Conformity Assessment of Class-III Medical Devices in Netherlands, 2007
    • Figure 86: Global Markets Direct Methodology